American Century Companies Inc. lifted its holdings in Owens & Minor, Inc. (NYSE:OMI – Free Report) by 15.3% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 210,338 shares of the company’s stock after purchasing an additional 27,851 shares during the quarter. American Century Companies Inc. owned 0.27% of Owens & Minor worth $1,899,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Fox Run Management L.L.C. bought a new position in shares of Owens & Minor in the first quarter worth $419,000. LHM Inc. lifted its holdings in shares of Owens & Minor by 66.6% in the first quarter. LHM Inc. now owns 292,942 shares of the company’s stock valued at $2,645,000 after buying an additional 117,150 shares during the period. Public Sector Pension Investment Board lifted its holdings in shares of Owens & Minor by 27.3% in the first quarter. Public Sector Pension Investment Board now owns 234,393 shares of the company’s stock valued at $2,117,000 after buying an additional 50,275 shares during the period. Nuveen LLC acquired a new stake in shares of Owens & Minor in the first quarter valued at $3,729,000. Finally, Invesco Ltd. lifted its holdings in shares of Owens & Minor by 19.9% in the first quarter. Invesco Ltd. now owns 1,716,895 shares of the company’s stock valued at $15,504,000 after buying an additional 285,060 shares during the period. Institutional investors own 98.04% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on OMI shares. Baird R W upgraded Owens & Minor from a “hold” rating to a “strong-buy” rating in a report on Friday, August 8th. JPMorgan Chase & Co. cut their price objective on Owens & Minor from $7.00 to $6.00 and set an “underweight” rating for the company in a report on Wednesday, August 27th. Bank of America cut their price objective on Owens & Minor from $7.50 to $4.75 and set an “underperform” rating for the company in a report on Tuesday, August 12th. UBS Group set a $7.00 price objective on Owens & Minor in a report on Wednesday, August 13th. Finally, Citigroup restated a “buy” rating and issued a $7.00 price objective (down previously from $11.00) on shares of Owens & Minor in a report on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $7.63.
Insiders Place Their Bets
In other Owens & Minor news, major shareholder Coliseum Capital Management, L purchased 720,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 12th. The shares were purchased at an average cost of $5.15 per share, with a total value of $3,708,000.00. Following the completion of the transaction, the insider owned 12,282,955 shares of the company’s stock, valued at approximately $63,257,218.25. This represents a 6.23% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders acquired 1,537,852 shares of company stock worth $8,099,544 over the last quarter. 3.69% of the stock is currently owned by insiders.
Owens & Minor Trading Down 1.1%
Shares of NYSE OMI opened at $4.91 on Tuesday. Owens & Minor, Inc. has a 12 month low of $4.56 and a 12 month high of $16.47. The company has a market cap of $378.94 million, a price-to-earnings ratio of -0.31 and a beta of 1.03. The company has a quick ratio of 0.83, a current ratio of 0.86 and a debt-to-equity ratio of 3.32. The business has a fifty day simple moving average of $7.05 and a 200-day simple moving average of $7.50.
Owens & Minor (NYSE:OMI – Get Free Report) last announced its earnings results on Monday, August 11th. The company reported $0.26 EPS for the quarter, missing the consensus estimate of $0.27 by ($0.01). Owens & Minor had a negative net margin of 13.78% and a positive return on equity of 26.59%. The company had revenue of $681.90 million for the quarter, compared to analysts’ expectations of $2.73 billion. During the same period in the prior year, the company earned $0.36 earnings per share. The company’s revenue for the quarter was up 3.3% on a year-over-year basis. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. Sell-side analysts predict that Owens & Minor, Inc. will post 1.51 EPS for the current year.
Owens & Minor Profile
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
Read More
- Five stocks we like better than Owens & Minor
- When to Sell a Stock for Profit or Loss
- 3 Healthcare Pathbreakers With Long-Term Tailwinds
- What is diluted earnings per share (Diluted EPS)?
- 3 Tariff-Proof Retailers Making New All-time Highs
- What is the Nikkei 225 index?
- With Shares Near Highs, Here’s to Watch in Broadcom’s Q3 Report
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.